Cleared Traditional

K072813 - EMMA ANALYZER (KPA & MMHG)

Also marketed or referenced as:
EMMA MONITOR (KPA & MMHG)

K072813 is an FDA 510(k) clearance for EMMA ANALYZER (KPA & MMHG), manufactured by Phasein AB. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K072813 · Phasein AB · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2007
Decision
88d
Days
Class 2
Risk

K072813 is an FDA 510(k) clearance for the EMMA ANALYZER (KPA & MMHG). Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Phasein AB (Madison, US). The FDA issued a Cleared decision on December 28, 2007 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Phasein AB devices

FDA 510(k) Submission Details - K072813

510(k) Number K072813 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 01, 2007
Decision Date December 28, 2007
Days to Decision 88 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 140d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 180
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K072813.
ACE/STATCHECK II CO2 INDICATOR, ACE/STATCHECK II CO2 INDICATOR ARM ASSEMBY ADULT STATCHECK RESUSCITATOR WITH ACE/STATCHE
K093525 · Ventlab Corp. · Dec 2009
NIHON KOHDEN CO2 SENSOR KIT, MODEL TG-970P
K083456 · Nihon Kohden America, Inc. · Mar 2009
VENTLAB NASAL CO2 SAMPLING/O2 DELIVERY CANNULA
K063813 · Ventlab Corp. · Mar 2008
YG-125T AND YG-135T NASAL ADAPTER
K072843 · Nihon Kohden America, Inc. · Nov 2007
CARBON DIOXIDE MONITOR, MODEL OLG-2800A
K062115 · Nihon Kohden America, Inc. · Dec 2006
DATEX-OHMEDA S/5 INTERFACE MODULE E-INT
K052880 · Ge Healthcare · Nov 2005